GeekWire July 18, 2024
Gillian Dohrn

Bonum Therapeutics is moving into new offices near Seattle’s South Lake Union neighborhood and plans to double its headcount in pursuit of immunotherapy drugs. The biotech startup will occupy the 11th floor of the Alexandria’s new life science tower at 1150 Eastlake Ave. E.

“We’re very excited about 1150,” said CEO John Mulligan. “It’s beautiful, great views. It’ll be a really fun space.”

Mulligan said Bonum discovered the vacancy during the biotech downturn in 2022. The Alexandria building is in an area of Seattle that’s home to multiple biotech startups and life science research organizations, such as Fred Hutchinson Cancer Research and The Allen Institute.

Bonum will move in August from its current offices in the nearby Access...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
How Americans feel about weight-loss drugs, in 3 charts
Drugmakers prep for bird flu outbreak, despite continued low risk
Heart health differences in men and women: Tiny RNA molecules play key role, study finds
STAT+: Nobel laureates call on National Academies and biotech CEOs to speak out against Trump attacks on science
Healthcare supply chain, pharmacy costs to rise in 2025: report

Share This Article